Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-084242
Filing Date
2021-06-22
Accepted
2021-06-22 18:13:47
Documents
1
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120371-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2120371-6_4seq1.xml 4 6098
  Complete submission text file 0001104659-21-084242.txt   7678
Mailing Address 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701
Business Address
INGRAM ROBERT ALEXANDER (Reporting) CIK: 0001219890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 211036590

Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)